CLOSED
NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%NIFTY 5022,453.30+0.98%SENSEX74,235.62+1.24%BANK NIFTY48,892.15+1.45%NIFTY IT35,124.80-0.52%NIFTY MIDCAP52,487.25+0.87%
Home/Business/BioticsAI CEO on FDA Approval & Startup …

BioticsAI CEO on FDA Approval & Startup Challenges

Business
By ThePip Desk•
Add as a preferred source on Google
A man and a woman in a modern office, engaged in a conversation for a podcast, with a folder labeled "FDA SUBMISSION" visible.

BioticsAI CEO Robhy Bustami discusses healthcare startup challenges and FDA approval with host Isabelle Johannessen.

Key Highlights

BioticsAI CEO Robhy Bustami shares insights on FDA approval, fundraising, and navigating healthcare startup challenges on Build Mode.

Robhy Bustami, CEO of BioticsAI, shared insights into the realities of building a company within the highly regulated healthcare sector during a recent appearance on Build Mode. Bustami joined host Isabelle Johannessen to discuss the company’s journey, focusing on key challenges such as obtaining FDA approval and securing funding.

The conversation highlighted the intricate process of navigating regulatory landscapes, often described as ‘red tape.’ Bustami elaborated on strategies BioticsAI employed to overcome these hurdles and maintain team motivation throughout the development process. The discussion aimed to provide a grounded perspective for entrepreneurs venturing into healthcare technology.

BioticsAIFDA